Showing results (291-300 of 5,264) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|October 14, 2019
Extending venous thromboembolism secondary prevention with apixaban in cancer patients: The EVE trialRobert D McBane, Charles L Loprinzi, Aneel Ashrani, et al.
European Journal of Haematology|October 14, 2019
Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphomaAgata Malenda, Agnieszka Kołkowska-Leśniak, Bartosz Puła, et al.
European Journal of Haematology|July 2, 2019
Feasibility of myelosuppressive chemotherapy in psychiatric patients on clozapine: A systematic review of the literatureBrian T Grainger, Murat O Arcasoy, Christopher A Kenedi
European Journal of Haematology|February 20, 2022
Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma: A population-based studyØystein O Langseth, Tor Å Myklebust, Tom B Johannesen, et al.
European Journal of Haematology|January 31, 2022
Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuriaAustin Kulasekararaj, Axel Glasmacher, Peng Liu, et al.
European Journal of Haematology|January 31, 2022
Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myelomaRam Vasudevan Nampoothiri, Ivan Pasic, Arjun Datt Law, et al.
European Journal of Haematology|March 17, 2022
Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first-line systemic treatment or best supportive care: A multicenter international studyTomoki Ito, David Sanford, Ciprian Tomuleasa, et al.
European Journal of Haematology|August 10, 2018
Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study)Jürgen Wehmeyer, Matthias Zaiss, Christoph Losem, et al.
European Journal of Haematology|September 5, 2018
Successful pregnancies in patients with BCR-ABL-positive leukemias treated with interferon-alpha therapy during the tyrosine kinase inhibitors eraMarie Balsat, Madeleine Etienne, Mohamed Elhamri, et al.
European Journal of Haematology|July 22, 2018
The effect of Bruton's tyrosine kinase (BTK) inhibitors on collagen-induced platelet aggregation, BTK, and tyrosine kinase expressed in hepatocellular carcinoma (TEC)Jun Chen, Taisei Kinoshita, Tarikere Gururaja, et al.
Pageof 527